Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia

NCT03692325 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Leukoplakia, Oral

Interventions

DRUG: Nivolumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]